Specialty Rheumatology
-
Featured
First Classification Criteria Developed for IgG4–Related Disease
The American College of Rheumatology and the European League Against Rheumatism that includes Massachusetts General Hospital physicians have developed and validated classification criteria for IgG4–related disease in a large cohort of patients.
-
Key Allergic Mediators of Eosinophilic Esophagitis Identified
Massachusetts General Hospital researchers have provided insight into the mechanisms that drive inflammation in eosinophilic esophagitis, including a novel pathway that may lead to recruitment of pathogenic effector T helper 2 cells to the esophagus and how these cells mediate eosinophilic inflammation.
-
Use of Rituximab, JAK Inhibitors at Time of COVID-19 Onset Increases Poor Outcomes
In a registry study of 2,869 patients with rheumatoid arthritis and COVID-19, Mass General Brigham researchers and colleagues found that use of rituximab or JAK inhibitors at the time of COVID-19 onset was associated with worse COVID-19 outcomes than for patients using tumor necrosis factor-α inhibitors.
-
Case Series: ECMO for Myositis-Associated Rapidly Progressive Interstitial Lung Disease
Based on the largest case series to date, Massachusetts General Hospital physicians recommend continued consideration of extra-corporeal membrane oxygenation as a bridge to recovery or transplant in patients with confirmed or suspected myositis-associated rapidly progressive interstitial lung disease.
-
Pilot Study: DASH Diet Reduces Serum Urate in Patients with Gout
Hyon K. Choi, MD, of the Division of Rheumatology, Allergy and Immunology, and colleagues report preliminary evidence that a dietitian-directed, DASH-patterned behavioral intervention lowers serum urate in gout patients not on urate-lowering drugs.
-
Using AI and Provider Notes to Study Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
Zachary S. Wallace, MD, MSc, of the Rheumatology Unit, and colleagues have demonstrated proof of concept that automated text mining of narrative chart notes is a feasible tool for studying the natural history of anti-neutrophil cytoplasmic antibody–associated vasculitis.
Rheumatology Contributors
-
Andrew D. Luster, MD, PhD
Chief of the Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Director of the Center for Immunology and Inflammatory Diseases
Recent Article
The Role of Atypical Chemoattractant Receptors in Recruiting Neutrophils into Inflamed Tissue Sites
-
Hak Soo Choi, PhD
Director, Bioengineering and Nanomedicine Program, Massachusetts General Hospital, Associate Professor of Radiology, Harvard Medical School, Faculty, Dana-Farber/Harvard Cancer Center
Recent Article
Tissue-Specific Contrast Agents for Optical Fluorescence to Evaluate Rheumatoid Arthritis -
John H. Stone, MD, MPH
Director, Clinical Rheumatology, Massachusetts General Hospital, Edward A. Fox Chair in Medicine at Mass General
Recent Article
Transforming Understanding of IGg4-Related Systemic Disease
-
Yuqing Zhang, DSc
Director of Epidemiological and Biostatistical Methods, Rheumatology Unit, Massachusetts General Hospital, Professor in Residence in Medicine, Harvard Medical School
Recent Article
Osteoarthritis of Knee or Hip Increases Risk of Venous Thromboembolism -
Zachary S. Wallace, MD, MSc
Physician, Rheumatology Unit, Massachusetts General Hospital
Recent Article
Use of Rituximab, JAK Inhibitors at Time of COVID-19 Onset Increases Poor Outcomes
Rheumatology
The Rheumatology Unit at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.
